Carriers of known or presumed GCGR LoF variants do not have an increased risk of all-cause dementia or Alzheimer's disease, but individuals with a cAMP LoF GCGR variant have lower cognitive function as evaluated by 1 population-scale cognitive test. Here, GCGR is linked to Alzheimer disease.